Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Apr 2026 for Kiniksa Pharmaceuticals International, plc, €35k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eben Tessari: trading record in brief
Eben Tessari (chief executive) discloses dealings in Kiniksa Pharmaceuticals International, plc to SEC (Form 4). We count 41 filings; the first trade dates from 15 July 2021 and the latest from 7 April 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 8 April 2026, reports a share grant of €35k in Kiniksa Pharmaceuticals International, plc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eben Tessari
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
846 shares@ US$48.9414.7% of flowClass A Ordinary ShareSEC:0001867899-26-000004:1
2,726 sharesClass A Ordinary ShareSEC:0001867899-26-000004:0
365 shares@ US$24.162.4% of flowClass A Ordinary ShareSEC:0001867899-26-000002:0
1,756 shares@ US$48.1322.7% of flowClass A Ordinary ShareSEC:0001867899-26-000002:2
5,975 sharesClass A Ordinary ShareSEC:0001867899-26-000002:1
6,000 shares@ US$8.832.3% of flowClass A Ordinary ShareSEC:0001867899-25-000013:0
200 shares@ US$22.890.2% of flowClass A Ordinary ShareSEC:0001867899-25-000011:0
6,500 shares@ US$8.832.6% of flowClass A Ordinary ShareSEC:0001867899-25-000009:0
6,500 shares@ US$8.832.7% of flowClass A Ordinary ShareSEC:0001867899-25-000007:0
42,000 shares@ US$17.9236.1% of flowClass A Ordinary ShareSEC:0001867899-25-000005:0
6,500 shares@ US$8.834.3% of flowClass A Ordinary ShareSEC:0001867899-25-000003:0
38,725 shares@ US$15.5047.3% of flowClass A Ordinary ShareSEC:0001415889-25-023878:0
1,746 sharesClass A Ordinary ShareSEC:0001415889-25-023587:0
6,500 shares@ US$8.838.6% of flowClass A Ordinary ShareSEC:0001415889-25-022460:0
752 shares@ US$15.631.9% of flowClass A Ordinary ShareSEC:0001415889-25-021271:0
6,500 shares@ US$8.839.6% of flowClass A Ordinary ShareSEC:0001415889-25-019841:0
6,500 shares@ US$8.8310.7% of flowClass A Ordinary ShareSEC:0001415889-25-017691:0
10,319 shares@ US$10.3622.5% of flowClass A Ordinary ShareSEC:0001415889-25-016722:0
7,000 shares@ US$3.8011.5% of flowClass A Ordinary ShareSEC:0001415889-25-013944:0
7,000 shares@ US$3.8011.4% of flowClass A Ordinary ShareSEC:0001415889-25-010808:0
2,726 sharesClass A Ordinary ShareSEC:0001415889-25-010487:0
1,773 sharesClass A Ordinary ShareSEC:0001415889-25-009998:0
1,964 sharesClass A Ordinary ShareSEC:0001415889-25-008616:0
7,000 shares@ US$3.8011.9% of flowClass A Ordinary ShareSEC:0001415889-25-007814:0
7,000 shares@ US$3.8012.5% of flowClass A Ordinary ShareSEC:0001415889-25-003748:0
25 of 41 declarations
